Literature DB >> 19934319

Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway.

Hiroshi Fukushima1, Fumitaka Koga, Satoru Kawakami, Yasuhisa Fujii, Soichiro Yoshida, Edward Ratovitski, Barry Trink, Kazunori Kihara.   

Abstract

p63 plays a critical role in normal development and maintenance of stratified epithelia, including the urothelium. In the normal urothelium, urothelial cells in the basal layers abundantly express the predominant p63 isoform DeltaNp63alpha. We previously showed that (a) DeltaNp63alpha expression at the similar level to the normal urothelium is retained in most low-grade papillary noninvasive (LPN) tumors, whereas frequently lost in high-grade invasive carcinomas, and that (b) loss of DeltaNp63alpha is associated with poor prognosis of invasive bladder urothelial carcinoma patients. However, a functional role of DeltaNp63alpha in progression of urothelial carcinomas remains to be elucidated. Here, we show that loss of DeltaNp63alpha expression promotes invasion of urothelial carcinoma cells. In 5637 cells substantially expressing only DeltaNp63alpha isoform at the protein level, knockdown of endogenous p63 upregulated N-cadherin, which recruited more Src homology and collagen to N-cadherin and activated extracellular signal-regulated kinase (ERK) signaling, and consequently potentiated cell motility, excretion of matrix metalloproteinase-9, and invasion. In T24 cells originally lacking endogenous DeltaNp63alpha expression, exogenous expression of DeltaNp63alpha attenuated invasion by downregulating N-cadherin expression and ERK activity, confirming an invasion-suppressive role of DeltaNp63alpha in urothelial carcinoma cells. We further documented loss of DeltaNp63 expression accompanied by N-cadherin upregulation during muscle-invasive recurrence in patients whose bladder cancer had progressed from LPN tumors to muscle-invasive disease. These results suggest that loss of DeltaNp63alpha and subsequent upregulation of N-cadherin is one of the mechanisms underlying progression of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19934319     DOI: 10.1158/0008-5472.CAN-09-1188

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  [Expressions of ΔNp63α, DPC4/Smad4 and P21 in cervical squamous cell carcinoma an their clinical significance].

Authors:  Wenqing Song; Tingting Huang; Lan Yu; Zenong Cheng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor β Signaling Pathway with Smad2 and IκB Kinase α in squamous cell carcinoma.

Authors:  Nahoko Fukunishi; Iyoko Katoh; Yoshiya Tomimori; Keiichi Tsukinoki; Ryu-Ichiro Hata; Atsuhito Nakao; Yoji Ikawa; Shun-Ichi Kurata
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

3.  Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression.

Authors:  Orit Karni-Schmidt; Mireia Castillo-Martin; Tian Huai Shen; Tian HuaiShen; Nataliya Gladoun; Josep Domingo-Domenech; Marta Sanchez-Carbayo; Yingchun Li; Scott Lowe; Carol Prives; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

4.  Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells.

Authors:  Manabu Tatokoro; Fumitaka Koga; Soichiro Yoshida; Satoru Kawakami; Yasuhisa Fujii; Len Neckers; Kazunori Kihara
Journal:  Int J Cancer       Date:  2011-11-10       Impact factor: 7.396

5.  Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.

Authors:  Marta Nekulova; Jitka Holcakova; Rudolf Nenutil; Rembert Stratmann; Pavla Bouchalova; Petr Müller; Lucie Mouková; Philip J Coates; Borivoj Vojtesek
Journal:  Virchows Arch       Date:  2013-07-26       Impact factor: 4.064

6.  ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.

Authors:  Linshan Hu; Shan Liang; Hu Chen; Tao Lv; Junfeng Wu; Deshi Chen; Min Wu; Shengnan Sun; Haibo Zhang; Han You; Hongbin Ji; Yujun Zhang; Johann Bergholz; Zhi-Xiong Jim Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-03       Impact factor: 11.205

7.  ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.

Authors:  Maria-Alexandra Papadimitriou; Margaritis Avgeris; Panagiotis K Levis; Theodoros Tokas; Konstantinos Stravodimos; Andreas Scorilas
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-08       Impact factor: 4.553

8.  Role of p63 in Development, Tumorigenesis and Cancer Progression.

Authors:  Johann Bergholz; Zhi-Xiong Xiao
Journal:  Cancer Microenviron       Date:  2012-07-31

Review 9.  p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.

Authors:  G Melino
Journal:  Cell Death Differ       Date:  2011-07-15       Impact factor: 15.828

10.  p63 controls cell migration and invasion by transcriptional regulation of MTSS1.

Authors:  A Giacobbe; M Compagnone; L Bongiorno-Borbone; A Antonov; E K Markert; J H Zhou; M Annicchiarico-Petruzzelli; G Melino; A Peschiaroli
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.